I received the following message from CenterWatch about clinical trials
in many locations for rasagiline. SEE summary of the study below and the
forwarded message. Is anyone already participating in a trial of this
drug?
Linda
"Trial Information
Summary: PRESTO (Parkinson's Rasagiline: Efficacy & Safety in the
Treatment of "OFF")
The Parkinson Study Group (PSG), in collaboration with Teva
Neurosciences, Inc., is conducting a study for patients with moderate to
advanced Parkinson's Disease. This 26-week study will examine the safety,
effectiveness and tolerability of an investigational drug in patients who
do not experience full benefit from their L-dopa dosage.
The study plans to recruit 450 subjects at 59 sites across the United
States and Canada. Enrollment began in September 2000. For more details,
contact one of the participating sites near you."
<http://www.centerwatch.com/patient/studies/stu30215.html>
--------- Forwarded message ----------
From: CenterWatch Patient Notification Service <[log in to unmask]>
Date: Sat Nov 3 06:42:19 2001
New clinical trials recently posted on the CenterWatch web site at
http://www.centerwatch.com.
1) PRESTO (Parkinson's Rasagiline: Efficacy & Safety in the Treatment of
"OFF"). This study is being conducted in:
- Toledo, OH
(http://www.centerwatch.com/patient/studies/stu30219.html)
- St. Louis, MO
(http://www.centerwatch.com/patient/studies/stu30204.html)
- Tampa, FL
(http://www.centerwatch.com/patient/studies/stu30191.html)
- Temple, TX
(http://www.centerwatch.com/patient/studies/stu30223.html)
- Rochester, NY
(http://www.centerwatch.com/patient/studies/stu30215.html)
- San Francisco, CA
(http://www.centerwatch.com/patient/studies/stu30177.html)
- Southfield, MI
(http://www.centerwatch.com/patient/studies/stu30202.html)
- Philadelphia, PA
(http://www.centerwatch.com/patient/studies/stu30220.html)
- Phoenix, AZ
(http://www.centerwatch.com/patient/studies/stu30171.html)
- Richmond, VA
(http://www.centerwatch.com/patient/studies/stu30226.html)
- Omaha, NE
(http://www.centerwatch.com/patient/studies/stu30205.html)
- Oxnard, CA
(http://www.centerwatch.com/patient/studies/stu30176.html)
- Pawtucket, RI
(http://www.centerwatch.com/patient/studies/stu30222.html)
- New York, NY
(http://www.centerwatch.com/patient/studies/stu30212.html)
- New York, NY
(http://www.centerwatch.com/patient/studies/stu30213.html)
- New York, NY
(http://www.centerwatch.com/patient/studies/stu30214.html)
- New Haven, CT
(http://www.centerwatch.com/patient/studies/stu30188.html)
- New Hyde Park, NY
(http://www.centerwatch.com/patient/studies/stu30211.html)
- New Orleans, LA
(http://www.centerwatch.com/patient/studies/stu30198.html)
- Miami, FL
(http://www.centerwatch.com/patient/studies/stu30190.html)
- Minneapolis, MN
(http://www.centerwatch.com/patient/studies/stu30203.html)
- New Brunswick, NJ
(http://www.centerwatch.com/patient/studies/stu30206.html)
- Little Rock, AR
(http://www.centerwatch.com/patient/studies/stu30170.html)
- Los Angeles, CA
(http://www.centerwatch.com/patient/studies/stu30175.html)
- Manhasset, NY
(http://www.centerwatch.com/patient/studies/stu30210.html)
- Irvine, CA
(http://www.centerwatch.com/patient/studies/stu30174.html)
- Jacksonville, FL
(http://www.centerwatch.com/patient/studies/stu30189.html)
- Kansas City, KS
(http://www.centerwatch.com/patient/studies/stu30197.html)
- Houston, TX
(http://www.centerwatch.com/patient/studies/stu30224.html)
- Indianapolis, IN
(http://www.centerwatch.com/patient/studies/stu30196.html)
- Iowa City, IA
(http://www.centerwatch.com/patient/studies/stu30194.html)
- Farmington, CT
(http://www.centerwatch.com/patient/studies/stu30187.html)
- Fountain Valley, CA
(http://www.centerwatch.com/patient/studies/stu30172.html)
- Fresno, CA
(http://www.centerwatch.com/patient/studies/stu30173.html)
- Cleveland, OH
(http://www.centerwatch.com/patient/studies/stu30218.html)
- Denver, CO
(http://www.centerwatch.com/patient/studies/stu30185.html)
- Denver, CO
(http://www.centerwatch.com/patient/studies/stu30186.html)
- Chicago, IL
(http://www.centerwatch.com/patient/studies/stu30195.html)
- Cincinnati, OH
(http://www.centerwatch.com/patient/studies/stu30216.html)
- Cleveland, OH
(http://www.centerwatch.com/patient/studies/stu30217.html)
- Boston, MA
(http://www.centerwatch.com/patient/studies/stu30199.html)
- Boston, MA
(http://www.centerwatch.com/patient/studies/stu30200.html)
- Charlottesville, VA
(http://www.centerwatch.com/patient/studies/stu30225.html)
- Augusta, GA
(http://www.centerwatch.com/patient/studies/stu30193.html)
- Baltimore, MD
(http://www.centerwatch.com/patient/studies/stu30201.html)
- Birmingham, AL
(http://www.centerwatch.com/patient/studies/stu30169.html)
- Albany, NY
(http://www.centerwatch.com/patient/studies/stu30208.html)
- Albequerque, NM
(http://www.centerwatch.com/patient/studies/stu30207.html)
- Atlanta, GA
(http://www.centerwatch.com/patient/studies/stu30192.html)
In addition to the CenterWatch patient notification service, through a
collaboration with The HealthExchange, patients can also be actively
matched to select clinical trials. Visit
http://www.centerwatch.com/thehealthexchange.html to learn more about the
HealthExchange Clinical Trials Matching Service.
---------------------------------------------------------
CenterWatch offers other publications and services that you can use to
learn about clinical trials for your medical condition. We publish a
series of reports that focus on specific illnesses. Each report provides
information about clinical trials results, drugs in development and
ongoing clinical studies. Visit
http://www.centerwatch.com/bookstore/pubs_cons_nmtform.html to see if
there is a report for you.
----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn
